Archives
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
4Q Design for Stable Polymeric mRNA Delivery
2026-08-28
Shi and colleagues introduced a 4Q framework that separates mRNA delivery into carrier stability, diffusion, cellular entry, and intracellular release. Their disulfide-containing polycatechol PBD formed mRNA complexes that remained stable at room temperature for more than two weeks and produced substantially stronger in vivo fluorescence than a jetPEI benchmark.
CCCP and Mitochondrial Morphology Assays
2026-08-28
CCCP (carbonyl cyanide m-chlorophenyl hydrazine) is more than an oxidative phosphorylation inhibitor: it can serve as a mechanistic challenge for interpreting mitochondrial morphology. This article connects CCCP-driven proton gradient disruption with deep-learning analysis of urine-derived stem cells in Alzheimer’s disease research.
6C Culture Medium Extends Mouse Corneal Epithelial Growth
2026-08-27
The reference study introduces a serum-free, multi-pathway 6C culture system that prolongs the proliferative activity of mouse corneal epithelial cells and improves epithelial-sheet production. Its practical significance lies in limiting epithelial–mesenchymal transdifferentiation while preserving progenitor-associated characteristics relevant to corneal repair and regenerative medicine.
Tricine-SDS-PAGE Gel Preparation Kit Guide
2026-08-27
The Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit (SKU K4136) is intended for high-resolution protein electrophoresis and peptide separation when conventional Tris-SDS-PAGE does not adequately resolve low-molecular-weight targets. It is a research-use gel-casting system for denaturing or non-denaturing electrophoresis, not for diagnostic, clinical, or medical testing.
Corydalis Alkaloids: PK Variability in MASH
2026-08-26
The reference study integrates pharmacokinetics, tissue distribution, transporter assays, and metabolic-enzyme analysis to show how MASH changes exposure to key Corydalis saxicola Bunting alkaloids. Its findings support disease-state-aware dosing and identify CYP450 enzymes, Oatp1b2, P-glycoprotein, and PXR as contributors to treatment-related variability.
URB597: Reliable FAAH Assay Workflows
2026-08-26
Learn how URB597 (SKU A4372) can support controlled FAAH and endocannabinoid experiments while avoiding common interpretation, solvent, and timing errors in cell-based workflows. This scenario-driven guide connects product specifications with practical assay design and translational limitations.
DAPT (GSI-IX): From Mechanism to Translation
2026-08-25
A mechanistic and strategic guide to using DAPT (GSI-IX) to interrogate γ-secretase, Notch signaling, APP processing, and organoid-based translational models.
DiD for Membrane-Resolved Inflammation Assays
2026-08-25
DiD (DiDC 18 (5)) enables membrane-resolved imaging for migration, fusion, neuronal tracing, and immunofluorescence workflows. This article explains how to use the probe as a spatial assay variable when studying macrophage inflammation and diabetic periodontitis models.
IGF2BP3–FZD1/7 Drives TNBC Stemness and Resistance
2026-08-24
The reference study identifies an IGF2BP3–FZD1/7 RNA-regulatory axis that links m6A recognition, β-catenin activation, cancer stem-like properties, and carboplatin resistance in triple-negative breast cancer. Its findings suggest that disrupting FZD1/7 signaling with Fz7-21 may sensitize TNBC stem-like cells to carboplatin, although clinical validation remains necessary.
Human iPSC Hepatobiliary Organoids: Study Insights
2026-08-24
Wu et al. developed a staged, three-dimensional system that generates hepatobiliary organoids from human induced pluripotent stem cells without exogenous cells or genetic manipulation. The organoids reproduced several hepatocyte and cholangiocyte functions, providing a defined platform for studying liver development, disease mechanisms, and drug responses.
Stattic: Reading STAT3 Signaling Across Cell Contexts
2026-08-23
Stattic is a STAT3 inhibitor that can function as more than a cancer-biology reagent: it is a causal probe for distinguishing pathway activation from downstream phenotype. This article connects HNSCC studies with new evidence from lymphatic endothelial cells and translates that comparison into practical assay decisions.
Cholecystokinin Octapeptide Ammonium: Assay Guide
2026-08-22
Cholecystokinin octapeptide ammonium is a sulfated CCK-8 research reagent for dissecting receptor-dependent brain–gut signaling. This guide connects salt-form handling with pathway-aware assays spanning ANP secretion, neuronal apoptosis, immune responses, and behavior.
Sulfo-NHS-SS-Biotin: Practical Labeling Guide
2026-08-22
Sulfo-NHS-SS-Biotin provides water-compatible labeling of accessible primary amines for reversible affinity capture and detection. It is suitable for protein and cell-surface workflows, but should not be used in amine-containing reaction buffers or when downstream reduction could disrupt native disulfide bonds.
Precision cDNA for HFpEF Gene Expression
2026-08-21
Translational cardiovascular studies depend on more than a measurable phenotype: they require an RNA-to-data workflow that preserves biological signal. Using TGFBR1-driven remodeling in HFpEF as a case study, this article explains how primer choice, reverse transcriptase performance, and validation strategy can strengthen mechanistic conclusions while positioning the HyperScript™ First-Strand cDNA Synthesis Kit for demanding gene expression workflows.
Intravesical p21 mRNA-LNP Therapy in Bladder Cancer
2026-08-20
This FASEB Journal study developed a nonviral lipid nanoparticle system for delivering chemically modified CDKN1A/p21 mRNA directly into the bladder. The approach restored nuclear p21, restrained tumor-associated cell-cycle activity, and reduced orthotopic bladder tumor growth while limiting systemic exposure in mice.
7872 records 7/525 page Previous Next First page 上5页 678910 下5页 Last page